HTSUF Revenue

Hisamitsu Pharmaceutical Co. had revenue of 34.67B JPY in the quarter ending May 31, 2025, a decrease of -3.20%. This brings the company's revenue in the last twelve months to 154.86B, up 6.49% year-over-year. In the fiscal year ending February 28, 2025, Hisamitsu Pharmaceutical Co. had annual revenue of 156.01B with 10.09% growth.

Revenue (ttm)

154.86B JPY

Revenue Growth

+6.49%

P/S Ratio

1.77

Revenue / Employee

55.33M JPY

Employees

2,799

Market Cap

1.90B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Feb 28, 2025	156.01B	14.30B	10.09%
Feb 29, 2024	141.71B	13.38B	10.42%
Feb 28, 2023	128.33B	8.14B	6.77%
Feb 28, 2022	120.19B	5.68B	4.96%
Feb 28, 2021	114.51B	-26.48B	-18.78%
Feb 29, 2020	Pro	Pro	Pro
Feb 28, 2019	Pro	Pro	Pro
Feb 28, 2018	Pro	Pro	Pro
Feb 28, 2017	Pro	Pro	Pro
Feb 29, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo, Inc.	1.73B
Veradigm	588.02M
Tian'an Technology Group	1.78M
Elite Pharmaceuticals	84.04M
Glass House Brands	215.62M
American Oncology Network	1.76B
Northwest Biotherapeutics	1.47M
Silence Therapeutics	27.70M

Revenue Rankings